Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Long-term Efficacy of Satralizumab in Patients with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Updated Analysis from the Open-label SAkuraMoon Study

              Author:Palace, Jacqueline   Traboulsee, Anthony   Saiz, Albert   De Seze, Jérôme   Kleiter, Ingo   Bennett, Jeffrey L.   Stokmaier, Daniela   Klingelschmitt, Gaëlle   Te-ying, Audrey Yeo   Vodopivec, Ivana   Yamamura, Takashi   

              Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

              Topic:Autoimmune Neurology  

              Program Number:S32.002  

              Author Institution:John Radcliffe Hospital, Oxford, United Kingdom , Oxford, United Kingdom  University of British Columbia, Vancouver, Canada, Vancouver, BC, Canada  Service of Neurology, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute, University of Barcelona, Barcelona, Spain , Barcelona, Spain  Hautepierre Hospital, Strasbourg, France , Strasbourg, France  Ruhr University Bochum, Bochum, Germany , Bochum, Germany  University of Colorado School of Medicine, Aurora, Colorado, USA, Aurora, CO  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  National Center of Neurology and Psychiatry, Tokyo, Japan, Tokyo, Japan  

              Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis

              Author:Mangioris, Georgios   Pittock, Sean   Yang, Binxia   Aksamit, Allen   Dubey, Divyanshu   Flanagan, Eoin   Lopez-Chiriboga, Sebastian   McKeon, Andrew   Mills, John   Vodopivec, Ivana   Tobin, W.   Toledano, Michel   Zekeridou, Anastasia   

              Session Name:S38: Autoimmune Neurology: Peripheral Autoimmunity, Paraneoplastic Disease, Checkpoint Inhibitors, and Neurosarcoidosis  

              Topic:Autoimmune Neurology  

              Program Number:S38.009  

              Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic, Jacksonville, FL  F. Hoffmann-La Roche Ltd, Basel, Switzerland  

              LUMINESCE, a Phase 3 Study of Satralizumab in Generalized Myasthenia Gravis (gMG): Baseline Characteristics

              Author:Habib, Ali A.   Zhao, Chongbo   Aban, Inmaculada   França Jr., Marcondes Cavalcante   José, Jorge Gustavo   Meyer zu Hörste, Gerd   Klimiec-Moskal, Elzbieta   Pulley, Michael T.   Tavolini, Darío   Krumova, Petranka   Lennon-Chrimes, Siân   Smith, Jillian   Thanei, Gian-Andrea   Vodopivec, Ivana   Wolfe, Gil I.   Murai, Hiroyuki   

              Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P10.015  

              Author Institution:University of California, Irvine, California, USA, Irvine, CA  Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China, Shanghai, China, People's Republic of  The University of Alabama at Birmingham, Birmingham, Alabama, USA, Birmingham, AL  Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil, Campinas, Brazil  CIMT Tucuman Medical Research Center, Hospital Ángel C. Padilla, Tucumán, Argentina, Tucumán, Argentina  University of Münster, Münster, Germany, Münster, Germany  Jagiellonian University Medical College, Krakow, Poland, Krakow, Poland  University of Florida College of Medicine, Jacksonville, Florida, USA, Jacksonville, FL  INECO Neurociencias Oroño, Rosario, Argentina, Rosario, Argentina  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/SUNY, Buffalo, New York, USA, Buffalo, NY  International University of Health and Welfare, Narita, Japan, Narita, Japan